Boards of directors of Claris Lifesciences and Mastek will meet on Tuesday and Wednesday, respectively, to consider a buyback proposal. Claris Lifesciences’ board will also discuss declaration of interim dividend subject to applicable laws. Currently, promoters hold a 60.21 per cent stake in the company, while FIIs own 14.77 per cent and domestic institutions 11.42
per cent. Some 14,250 retail investors control a 4.98 per cent stake in the company. In IT major Mastek, about 15,000 retail investors have an exposure of 26.1 per cent stake in the company. While Mastek is ruling at Rs 162, Claris on Friday closed at Rs 200.